Urgo Healthcare accelerates its European growth with three acquisitions in 2025
Urgo Healthcare, with a turnover of €311 million and 1,100 employees, is a key player in everyday healthcare, with flagship brands such as Urgo, Alvityl, Humer and Belloc, which have been part of French people’s lives for generations. As a leader in first aid, dietary supplements and hygiene, the company places innovation at the heart […]
⭐ 𝗨𝗥𝗚𝗢 𝗚𝗿𝗼𝘂𝗽 𝗼𝗯𝘁𝗮𝗶𝗻𝘀 𝟮𝟬𝟮𝟲 𝗛𝗮𝗽𝗽𝘆𝗜𝗻𝗱𝗲𝘅® 𝗧𝗿𝗮𝗶𝗻𝗲𝗲𝘀 𝗹𝗮𝗯𝗲𝗹!
At URGO Group, knowledge transfer is part of our DNA. We are proud to support the talents of tomorrow and give them the tools to grow professionally. Receiving this label encourages us to continue our mission: 🔹 to offer a stimulating and supportive learning environment, 🔹 to fully involve young talent in our projects, 🔹 […]
Juva Santé acquires the Ricqlès brand and strengthens its leadership in the oral health market
Laboratoires Juva Santé, a subsidiary of the Urgo Group and a major player in consumer healthcare (Juvamine, Mercurochrome), announces the definitive acquisition of the Ricqlès brand from the Haribo Group in Europe and other territories*. After successfully operating under license in France since 2020 in mass retail, Juva Santé, now the owner of the heritage […]
The URGO Group is investing €60 million in the construction of a new factory in the Loire region!
The URGO Group has taken another strategic step forward with the announcement of a €60 million investment in the construction of its fifth French industrial site, in order to support the strong growth of its medical compression range. Located in Andrézieux-Bouthéon (Loire), this 35,000 m² factory will create 200 direct jobs and 115 indirect jobs […]
When fashion meets health!
In September 2024, a unique project was launched behind the scenes, in collaboration with the Académie des Arts Appliqués de Dijon, renowned for its expertise in fashion, graphic design and interior architecture. 🔹 The goal? To give a second life to production scraps from our industrial sites in Chevigny-Saint-Sauveur and Veauche… by transforming them into […]
Making a difference during European Sustainable Development Week 🤝
European Sustainable Development Week is an annual highlight for mobilising, raising awareness and promoting actions in favour of sustainable development across Europe. From 15 to 19 September 2025, teams at the Chenôve site focused on topics related to climate change adaptation, such as biodiversity, mobility and sustainability. On the agenda: Discovering the role of pollinators […]
URGO Group inaugurates its new data center!
URGO takes another step forward in its digital transformation! On Friday 27 June, we inaugurated our new server infrastructure at the DTiX Datacenters data centre in Dijon in the presence of Prefect Paul Mourier, Minister and President of the Dijon Metropolis François Rebsamen, and Mayor of Dijon Nathalie Koenders. This strategic step marks a major […]
Artificial skin: URGO opens its new laboratory!
On 16th December 2022, on the URGO site in Chenôve, near Dijon, François Braun, the Minister of Health and Prevention, officially opened the GENESIS Laboratory. GENESIS is the artificial skin development project, undertaken jointly by teams from URGO and a consortium of four partners at the forefront of French excellence. The aim? To heal severe […]
URGO in the spotlight on Europe 1!
On 21st November 2022, Tristan Le Lous, Chairman of Urgo Group, was one of the guests on “La France Bouge” on Europe 1. This programme looks around France for positive and pioneering initiatives and showcases those that push the boundaries and break the mould! From the historic bandage to the development of artificial skin, Tristan […]
Laboratoires URGO Healthcare 1st in the Pharmascope OTC Gallileo ranking
Each year, the Galliléo Institute conducts a study on the reputation and image of self-medication laboratories among pharmacists in France. In 2022, for the seventh year in a row, URGO Healthcare was recognized by pharmacists as the best performing laboratory! Its operational excellence, its strategy of frequent and relevant innovations, its pricing policy and its […]